Investor Presentaiton

Cash flow DKKM EBIT H1 2021/22 H1 2022/23 Change 2,920 3,412 17% Amortisation 87 167 92% Depreciation 324 362 12% Adjustment for other non-cash operating items 172 -81 nm Change in working capital -1,086 -1,289 19% Net interest payments Paid tax Cash flow from operations Investment in intangibles CAPEX¹ Investment in other investments Acquisition of subsidiaries -52 -143 175% -984 -1,252 27% 1,381 1,176 -15% -61 -134 120% -402 -430 7% -17 nm -10,633 nm Securities 200 nm Cash flow from investments -11,096 -381 nm Free cash flow -9,715 795 nm Dividends -2,979 -3,185 7% Net aquisition of treasury shares and exercise of share options Repayment of lease liabilities -435 7 -102% -107 -119 11% Financing through issuing long-term bonds 16,373 nm Hedging gain nm Drawdown on credit facilities -3,081 2,748 -189% 1) Net CAPEX including divestment of PPE and excluding finance leases 94 Coloplast

View entire presentation